Connect with us
News Releases3 days ago

Therma Bright Prepares Launch of Digital Cough Screening and Data Collection Smartphone Application

Toronto, Ontario--(Newsfile Corp. - March 23, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer...
News Releases2 days ago

Silo Wellness Secures Right of First Refusal on All Psilocybin Mushroom Biomass from Medford, Oregon First-Mover Satya; Other Corporate Updates
News Releases3 days ago

Psyched Wellness Is Excited to Announce That Calm Has Been Listed on the World’s Largest E-Commerce Marketplace, Amazon.com
Companies3 days ago

Cognetivity Neurosciences Unveils Groundbreaking Research on Cognition and Sleep, Extends Collaboration with University of Oxford

Latest

Companies1 day ago

IntelGenx Revises Fourth Quarter and Full Year 2022 Financial Results Reporting and Conference Call Date to March 29, 2023

SAINT LAURENT, Quebec, March 24, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical...
News Releases1 day ago

Premier Health Files Amendment to Its Management Information Circular Dated February 17, 2023, and Announces Results of Shareholders’ Meeting
Financing2 days ago

Knight Therapeutics Inc. ranks on The Globe and Mail’s fourth-annual Women Lead Here benchmark of executive gender diversity
Financing2 days ago

Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Clinical Trials2 days ago

Spectral Medical Announces Fourth Quarter and Fiscal 2022 Results and Provides Corporate Update
Financing2 days ago

Bioasis Provides Update on Business Operations
Clinical Trials2 days ago

Aptose Reports Results for the Fourth Quarter and Full Year 2022

Trending

Financing6 days ago

Resverlogix Announces One-Year Extension of Debenture
News Releases5 days ago

Red Light Holland Looking Forward to AGSM, Including Corporate Update from Chairman Brad J Lamb and a Live Q&A With CEO Todd Shapiro on March 23rd at 11 AM
News Releases6 days ago

AC Immune at AD/PD™ 2023 to Present New Clinical and Preclinical Data from its Precision Medicine Pipeline
News Releases5 days ago

Operational Update
Financing4 days ago

Dialogue Health Technologies Reports Fourth Quarter and Full Year 2022 Results
News Releases6 days ago

Governments of Ontario and Canada Invest in Microbix
News Releases4 days ago

WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2022 FINANCIALS AND OPERATIONS AND FILING OF ITS 2022 AIF
News Releases4 days ago

PepGen to Participate in the Stifel 2023 CNS Days Conference
News Releases1 day ago

Premier Health Files Amendment to Its Management Information Circular Dated February 17, 2023, and Announces Results of Shareholders’ Meeting
Financing3 days ago

Titan Medical Announces Delays in its Annual Filings and Planned Deregistration with the SEC

Today’s News

Today’s News6 months ago

Lobe Sciences Announces Incorporation of Australian Subsidiary

Vancouver, British Columbia--(Newsfile Corp. - September 23, 2022) -  Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"),...
Today’s News6 months ago

Bausch Health and Glenmark Announce the approval of RYALTRIS® in Canada
Today’s News6 months ago

Nirvana Life Sciences Inc. Deuterates 7-Hydroxymitragynine to Create D7-h, an Analogue that May Improve Research and Formulations using Kratom Derivatives
Today’s News6 months ago

Universal Ibogaine Announces Kelburn Reopening Date
Today’s News6 months ago

Bausch + Lomb Announces Webinar for Eye Care Professionals on New AREDS2 Study Findings
Today’s News6 months ago

Breakthrough Results with Accum(TM) A1-Reprogrammed MSC, Mesenchymal Stem Cells, in a Novel Vaccine Cured 80% of Animals with Pre-Established Lymphoma
Today’s News6 months ago

Dialogue Provides Business Update and Outlook for the Third Quarter of 2022
Today’s News6 months ago

Think Research Announces Approximately $12.8 Million of New BioPharma Contracts Signed During Q3 2022
Today’s News6 months ago

Neovasc Provides Corporate Update Following Clinical Data Release
More Today’s News

News Releases

News Releases4 days ago

Lobe Sciences Ltd. Announces That The Drug Enforcement Administration Has Issued The Initial 2023 Quota Allowing Export Of L-130

Dosing In Human Clinical Trial To Commence Within WeeksVancouver, British Columbia--(Newsfile Corp. - March 22, 2023) - Lobe Sciences Ltd....
News Releases4 days ago

WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2022 FINANCIALS AND OPERATIONS AND FILING OF ITS 2022 AIF
News Releases4 days ago

Dialogue Health Technologies Reports Fourth Quarter and Full Year 2022 Results
News Releases4 days ago

Dermatophytic Onychomycosis Treatment Market to Reach USD 9,801 Mn by 2032, North America Dominates with 43% of the Market Share
News Releases5 days ago

Operational Update
News Releases5 days ago

Red Light Holland Looking Forward to AGSM, Including Corporate Update from Chairman Brad J Lamb and a Live Q&A With CEO Todd Shapiro on March 23rd at 11 AM
News Releases6 days ago

Resverlogix Announces One-Year Extension of Debenture
News Releases1 week ago

Defence Therapeutics Announces Exercise of Warrants for Gross Proceeds of over $5 Million
News Releases1 week ago

Universal Ibogaine Announces Revision to Terms of Offering of Convertible Debt Securities
More News Releases

More News